These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 8335949

  • 1. Induction of HIVMN neutralizing antibodies in primates using a prime-boost regimen of hybrid synthetic gp120 envelope peptides.
    Haynes BF, Torres JV, Langlois AJ, Bolognesi DP, Gardner MB, Palker TJ, Scearce RM, Jones DM, Moody MA, McDanal C.
    J Immunol; 1993 Aug 01; 151(3):1646-53. PubMed ID: 8335949
    [Abstract] [Full Text] [Related]

  • 2. Synthetic peptides containing T and B cell epitopes from human immunodeficiency virus envelope gp120 induce anti-HIV proliferative responses and high titers of neutralizing antibodies in rhesus monkeys.
    Hart MK, Palker TJ, Matthews TJ, Langlois AJ, Lerche NW, Martin ME, Scearce RM, McDanal C, Bolognesi DP, Haynes BF.
    J Immunol; 1990 Oct 15; 145(8):2677-85. PubMed ID: 1698859
    [Abstract] [Full Text] [Related]

  • 3. Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes.
    Palker TJ, Matthews TJ, Langlois A, Tanner ME, Martin ME, Scearce RM, Kim JE, Berzofsky JA, Bolognesi DP, Haynes BF.
    J Immunol; 1989 May 15; 142(10):3612-9. PubMed ID: 2469721
    [Abstract] [Full Text] [Related]

  • 4. Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations.
    Ahlers JD, Pendleton CD, Dunlop N, Minassian A, Nara PL, Berzofsky JA.
    J Immunol; 1993 Jun 15; 150(12):5647-65. PubMed ID: 8515081
    [Abstract] [Full Text] [Related]

  • 5. Importance of conformation on the neutralizing antibody response to HIV-1 gp120.
    Steimer KS, Haigwood NL.
    Biotechnol Ther; 1991 Jun 15; 2(1-2):63-89. PubMed ID: 1726963
    [Abstract] [Full Text] [Related]

  • 6. Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting.
    Richmond JF, Mustafa F, Lu S, Santoro JC, Weng J, O'Connell M, Fenyö EM, Hurwitz JL, Montefiori DC, Robinson HL.
    Virology; 1997 Apr 14; 230(2):265-74. PubMed ID: 9143282
    [Abstract] [Full Text] [Related]

  • 7. A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIV gp120.
    Greenstein JL, Schad VC, Goodwin WH, Brauer AB, Bollinger BK, Chin RD, Kuo MC.
    J Immunol; 1992 Jun 15; 148(12):3970-7. PubMed ID: 1376346
    [Abstract] [Full Text] [Related]

  • 8. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY, Luo L, Wainberg MA, Li Y.
    Biol Chem; 1999 Mar 15; 380(3):353-64. PubMed ID: 10223338
    [Abstract] [Full Text] [Related]

  • 9. Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein.
    Haynes BF, Arthur LO, Frost P, Matthews TJ, Langlois AJ, Palker TJ, Hart MK, Scearce RM, Jones DM, McDanal C.
    J Exp Med; 1993 Mar 01; 177(3):717-27. PubMed ID: 7679708
    [Abstract] [Full Text] [Related]

  • 10. Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120.
    Gorny MK, Xu JY, Karwowska S, Buchbinder A, Zolla-Pazner S.
    J Immunol; 1993 Jan 15; 150(2):635-43. PubMed ID: 7678279
    [Abstract] [Full Text] [Related]

  • 11. Design and synthesis of a self-assembling peptide derived from the envelope proteins of HIV type 1. An approach to heterovalent immunogens.
    Tripathy SP, Kumar A, Manivel V, Panda SK, Rao KV.
    J Immunol; 1992 Jun 15; 148(12):4012-20. PubMed ID: 1534827
    [Abstract] [Full Text] [Related]

  • 12. Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A).
    Staats HF, Nichols WG, Palker TJ.
    J Immunol; 1996 Jul 01; 157(1):462-72. PubMed ID: 8683152
    [Abstract] [Full Text] [Related]

  • 13. The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope.
    Benferhat R, Martinon F, Krust B, Le Grand R, Hovanessian AG.
    Mol Immunol; 2009 Feb 01; 46(4):705-12. PubMed ID: 19010547
    [Abstract] [Full Text] [Related]

  • 14. Priming with T helper cell epitope peptides enhances the antibody response to the envelope glycoprotein of HIV-1 in primates.
    Hosmalin A, Nara PL, Zweig M, Lerche NW, Cease KB, Gard EA, Markham PD, Putney SD, Daniel MD, Desrosiers RC.
    J Immunol; 1991 Mar 01; 146(5):1667-73. PubMed ID: 1704401
    [Abstract] [Full Text] [Related]

  • 15. Conformational preferences of a chimeric peptide HIV-1 immunogen from the C4-V3 domains of gp120 envelope protein of HIV-1 CAN0A based on solution NMR: comparison to a related immunogenic peptide from HIV-1 RF.
    Vu HM, de Lorimier R, Moody MA, Haynes BF, Spicer LD.
    Biochemistry; 1996 Apr 23; 35(16):5158-65. PubMed ID: 8611499
    [Abstract] [Full Text] [Related]

  • 16. Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression.
    Zwart G, van der Hoek L, Valk M, Cornelissen MT, Baan E, Dekker J, Koot M, Kuiken CL, Goudsmit J.
    Virology; 1994 Jun 23; 201(2):285-93. PubMed ID: 7514319
    [Abstract] [Full Text] [Related]

  • 17. A combinatorial peptide library around variation of the human immunodeficiency virus (HIV-1) V3 domain leads to distinct T helper cell responses.
    Estaquier J, Boutillon C, Georges B, Ameisen JC, Tartar A, Auriault C.
    J Pept Sci; 1996 Jun 23; 2(3):165-75. PubMed ID: 9231325
    [Abstract] [Full Text] [Related]

  • 18. Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins.
    Mascola JR, Sambor A, Beaudry K, Santra S, Welcher B, Louder MK, Vancott TC, Huang Y, Chakrabarti BK, Kong WP, Yang ZY, Xu L, Montefiori DC, Nabel GJ, Letvin NL.
    J Virol; 2005 Jan 23; 79(2):771-9. PubMed ID: 15613305
    [Abstract] [Full Text] [Related]

  • 19. Monoclonal anti-idiotypic antibody mimicking the principal neutralization site in HIV-1 GP120 induces HIV-1 neutralizing antibodies in rabbits.
    Fung MS, Sun CR, Liou RS, Gordon W, Chang NT, Chang TW, Sun NC.
    J Immunol; 1990 Oct 01; 145(7):2199-206. PubMed ID: 2398276
    [Abstract] [Full Text] [Related]

  • 20. Focusing the immune response on the V3 loop, a neutralizing epitope of the HIV-1 gp120 envelope.
    Zolla-Pazner S, Cohen SS, Krachmarov C, Wang S, Pinter A, Lu S.
    Virology; 2008 Mar 15; 372(2):233-46. PubMed ID: 18061228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.